MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹925 Cr | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹925 Cr |
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹925 Cr | -9.29 | |
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹105,108.5 Cr | 3.4% | 6.6% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 3.4% |
6.6% |
-4.8% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses